Bieber, T. ., L. Beck, A. Pink, H. Saeki, L. Eichenfeld, T. Werfel, A. Rosholm, M. Ropke, and A. . Paller. ‚ÄúNeutralizing Interleukin-13 Increases Skin Microbial Diversity: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Tralokinumab in Adult Patients With Atopic Dermatitis‚ÄĚ. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 6, Nov. 2021, p. s56, doi:10.25251/skin.5.supp.56.